ドイツの在宅検査キット市場
Market Size in USD Billion
CAGR : %
予測期間 |
2024 –2030 |
市場規模(基準年) |
|
Market Size (Forecast Year) |
|
CAGR |
|
主要市場プレーヤー |
>ドイツの在宅検査キット市場、検査タイプ別(美容とウェルネス、健康、栄養、妊娠検査、性感染症検査、排卵予測検査キット、薬物乱用検査キット、その他の検査タイプ)、タイプ別(カセット、ストリップ、ミッドストリーム、検査パネル、ディップカード、その他)、年齢別(小児、成人、高齢者)、サンプルタイプ別(尿、血液、唾液、その他のサンプルタイプ)、所得別(低所得、中所得、高所得)、使用法別(使い捨て、再利用可能)、流通チャネル別(小売薬局、ドラッグストア、スーパーマーケット/ハイパーマーケット、オンライン薬局)– 2030年までの業界動向と予測。
ドイツの在宅検査キット市場分析と規模
ドイツの在宅検査キット市場は、いくつかの製品に対する認知度の高まりにより、成長が見込まれています。在宅または自己検査キットは薬局で簡単に入手でき、入手が非常に簡単になりました。さまざまな医療会社が自己検査キットを急速に製造し、この分野に進出しています。
この幅広い入手性は、オンライン薬局の医療スタートアップによるものでもあり、ボタンをクリックするだけで簡単に入手できるようになっています。さらに、これらのセルフテストキットは処方箋なしで入手できるため、自宅テストキット市場を牽引する可能性があります。自宅テストキットを使用すると、エンドユーザーは自宅で検体を採取して自宅で検査するか、ラボに送って検査することができます。自宅テストキットは、自宅での妊娠検査であれ、HIV検査であれ、その他の感染症検査であれ、人の懸念を確認するプロセスを間違いなく容易にしました。
これらの家庭用検査は使いやすく、価格も手頃です。しかし、結果の正確性には常に疑問があり、市場の成長を抑制すると予想されます。しかし、偽陽性の検査結果は、たとえ感染していなくても、不安やストレスを引き起こす可能性があります。偽陽性または偽陰性の結果を受け取ることは、非常に動揺し、不安になります。現在、多くの企業が自宅で実施できるCOVID-19の迅速診断検査キットを製造しています。しかし、精度に関連するさまざまな問題があるため、信頼性を検証するために、これらの家庭用検査キットの配布が停止されています。
Data Bridge Market Researchは、ドイツの在宅検査キット市場は2023年から2030年にかけて10.5%のCAGRで成長すると予測していると分析しています。
レポートメトリック |
詳細 |
予測期間 |
2023年から2030年 |
基準年 |
2022 |
歴史的な年 |
2021 (2015 - 2020 にカスタマイズ可能) |
定量単位 |
収益は百万ドル、価格は米ドル |
対象セグメント |
Test Type (Beauty and Wellness, Health, Nutrition, Pregnancy Test, STD Test, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Other Sample Types), Income (Low Income, Middle Income, and High Income), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies) |
Country Covered |
Germany |
Market Players Covered |
Abbott, Siemens Healthcare GmbH, F. Hoffman- La Roche Ltd, Quidel Corporation, Cardinal Health, bioLytical Laboratories Inc., kiweno GmbH, Nova Biomedical, Johnson & Johnson Services, Inc., and B. Braun SE among others |
Market Definition
At-home testing kits help the person to perform tests at home and give them rapid results in a minute. They also include monitoring equipment to check and control the health of diabetic patients continuously. At-home tests are convenient to perform comfortably and are available at a very affordable rate. Self-tests are usually the advanced versions of rapid, point-of-care test kits originally designed for healthcare professionals and can be performed by the common person. Their processes, packaging, and instructions have been simplified to guide a person through the steps of taking a test. Various at-home test kits are available, including beauty test kits, H.I.V. tests, pregnancy tests, diabetes, ovulation test, and infectious diseases such as malaria, influenza, and others. Blood, urine, and oral fluid can be taken as a sample for performing these rapid at-home tests.
Germany At-Home Testing Kits Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rise in the adoption of at-home testing kits due to the increase in the prevalence of health disorders
With rising economic growth, people are more interested in long-term health and wellness. Diabetic patients need devices to monitor their sugar levels; checking pregnancy increases the demand for pregnancy strips; monitoring of blood pressure results in demand for devices such as blood pressure monitors and sphygmomanometers; stress and anxiety increase the demand for stress test kits and others. Along with managing the disorder, it also helps check skin and other body-related issues such as allergies.
Earlier, people often visited hospitals/clinics/diagnostic centers for basic problems. However, as awareness has grown regarding several products, such as at-home testing kits for beauty and wellness, health, nutrition, and others, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor or technician.
This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has become a boon in disguise for hospitals/clinics/ diagnostic centers and patients, as hospitals/clinics/diagnostic centers are already stretched thin and can entirely focus on COVID-19 patients. The patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their test results at their fingertips.
Thus, the rising adoption of at-home testing kits due to convenience and rapid results is expected to drive market growth.
- Easy availability of self-testing kits at pharmacies and online stores
At-home or self-testing kits are easily available at pharmacy stores and online stores, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.
This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.
Specialty online shops, emerging digital marketplaces, e-commerce, and internet advertising are further attracting the market. Online stores provide much-needed privacy options with doorstep delivery, widening their market reach.
Thus, self-testing kits have become widely available for various diseases due to the rapid manufacturing by medical testing companies and are expected to drive market growth.
Opportunity
- Expanding business through subsidiaries
Companies operate their business through subsidiaries around the world. This would help the company to generate more revenue by serving a large customer base through its subsidiaries, which will create the opportunity for the company to expand its business and generate more revenue. Players with a major percentage share in the market alone are continuously expanding the health wellness business through their subsidiaries; they have a presence almost globally. This helps them to attract more customers and create a database of customers across various regions, ultimately helping them to identify the region and countries which require more focus and plans for helping the healthcare customers to make structural decisions.
This syndicates that the company is operating its business through its number of subsidiaries in different regions of the world. This helped the company generate more revenue and create an opportunity for market growth.
Restraint/Challenge
- Inaccuracy of results by self-testing kits
At-home testing kits allow end-users to collect their specimen at home and perform it at home or send it to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test or HIV, or any other infectious diseases tests.
These home tests are easy to use and affordable too. However, there is always doubt about the accuracy of the results. STD home monitoring can be more comfortable than visiting a hospital or doctor's office. It will also help reduce the risk of the STD being spread or acquired when you are screened.
However, a false-positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for STDs, diabetes, and others, which can be performed at home. But there are various accuracy-related issues, so the distribution of those at-home test kits has been suspended from verifying their reliability.
Various factors can cause false results, such as manufacturing defects, low feasibility, incorrect instructions, or misinterpreting results.
Thus, end-users doubt the reliability of the rapid home testing kits, which is expected to restrain the market growth.
Recent Development
- In April 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had cleared a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system, which features the world's smallest, thinnest, and most discreet5 glucose sensor. With the FDA's clearance of a standalone reader, the company will have expected to generate more revenue.
Germany At-Home Testing Kits Market Scope
Germany at-home testing kits market is categorized into seven notable segments based on test type, type, income, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Test Type
- Beauty and Wellness
- Health
- Nutrition
- Pregnancy Test
- STD Test Kit
- Ovulation Predictor Test Kit
- Drug Abuse Test Kit
- Others Test Types
On the basis of test type, the market is segmented into beauty and wellness, health, nutrition, pregnancy test, STD test kit, ovulation predictor test kit, drug abuse test kit, and other test types.
Type
- Cassette
- Strip
- Midstream
- Test Panel
- Dip Card
- Others
On the basis of type, the market is segmented into cassette, strip, midstream, test panel, dip card, and others.
Income
- Low Income
- Middle Income
- High Income
On the basis of income, the market is segmented into low income, middle income, and high income.
Age
- Pediatric
- Adult
- Geriatric
On the basis of age, the market is segmented into pediatric, adult, and geriatric.
Sample Type
- Urine
- Blood
- Saliva
- Other Sample Types
On the basis of sample type, the market is segmented into urine, blood, saliva, and others sample types.
Usage
- Disposable
- Reusable
On the basis of usage, the market is segmented into disposable and reusable.
Distribution Channels
- Retail Pharmacies
- Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
流通チャネルに基づいて、市場は小売薬局、ドラッグストア、スーパーマーケット/ハイパーマーケット、オンライン薬局に分類されます。
競争環境とドイツの在宅検査キット市場シェア分析
ドイツの在宅検査キット市場の競争状況は、競合他社の詳細を提供します。会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、国でのプレゼンス、生産拠点と施設、会社の強みと弱み、製品の発売、臨床試験パイプライン、ブランド分析、製品承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などの詳細が含まれます。上記のデータ ポイントは、市場に対する会社の重点にのみ関連しています。
ドイツの在宅検査キット市場で活動している主要な市場プレーヤーとしては、Abbott、Siemens Healthcare GmbH、F. Hoffman-La Roche Ltd、Quidel Corporation、Cardinal Health、bioLytical Laboratories Inc.、kiweno GmbH、Nova Biomedical、Johnson & Johnson Services、Inc.、B. Braun SEなどが挙げられます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GERMANY AT-HOME TESTING KITS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE
2.8 MARKET POSITION COVERAGE GRID
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC INITIATIVES
4.4 BRAND ANALYSIS
4.5 PRICING ANALYSIS
5 GERMANY AT-HOME TESTING KITS MARKET: REGULATIONS
5.1 REGULATION IN EUROPE
5.2 GUIDELINES FOR TESTING KITS
6 GERMANY AT-HOME TESTING KITS MARKET, MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN THE ADOPTION OF AT-HOME TESTING KITS DUE TO THE INCREASE IN THE PREVALENCE OF HEALTH DISORDERS
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF STD DIAGNOSIS
6.1.4 LOW COST AND EASE TO USE AT-HOME TEST KITS
6.2 RESTRAINTS
6.2.1 PRODUCT RECALL OF AT-HOME TESTING KITS
6.2.2 INACCURACY OF RESULTS BY SELF-TESTING KITS
6.2.3 STRINGENT GOVERNMENT REGULATIONS FOR THE MANUFACTURING AND DISTRIBUTION OF TESTING KITS
6.3 OPPORTUNITIES
6.3.1 EXPANDING BUSINESS THROUGH SUBSIDIARIES
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS
6.4 CHALLENGES
6.4.1 LOW AWARENESS IN SOCIETY
6.4.2 REDUCTION IN THE R&D BUDGET
7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 HEALTH
7.2.1 DIABETES KITS
7.2.2 KIDNEY FUNCTION TEST KITS
7.2.3 LIVER FUNCTION TEST KITS
7.2.4 PROTEIN KITS
7.2.5 IRON STATUS KITS
7.2.6 HEART DISEASE RISK TEST KITS
7.2.7 THYROID FUNCTION
7.2.8 RED BLOOD CELLS
7.2.9 WHITE BLOOD CELLS
7.2.10 CLOTTING STATUS
7.2.11 HORMONE
7.2.12 PSA
7.2.13 MENOPAUSE TEST
7.2.14 ANXIETY
7.2.15 ASTHMA
7.2.16 ATRIAL FIBRILLATION
7.2.17 GOUT
7.2.18 HDL AND LDL CHOLESTROL TEST KITS
7.2.19 HIGH BLOOD PRESSURE
7.2.20 OTHERS
7.3 BEAUTY AND WELLNESS
7.3.1 SKIN MICROBIME TEST
7.3.2 GENETIC BASED TEST KITS
7.3.3 FOOD SENSITIVITY TEST KITS
7.3.4 SEX HORMONE
7.3.4.1 FEMALE HORMONE TEST
7.3.4.2 MALE HORMONE TEST
7.3.5 HAIR, NAILS AND SKIN TEST KITS
7.3.6 STRESS TEST KITS
7.3.7 ALCOHOL FLUSH REACTION
7.3.8 CAFFEINE CONSUMPTION
7.3.9 DEEP SLEEP
7.3.10 MUSCLE COMPOSITION
7.3.11 SATURATED FAT
7.3.12 SLEEP MOVEMENT
7.3.13 ALLERGY TESTING
7.3.14 INTOLERANCE TESTING
7.3.14.1 LACTOSE INTOLERANCE
7.3.14.2 VEGAN INTOLERANCE TESTING
7.3.14.3 OTHER TEST
7.3.15 GUT MICROBIOME TEST
7.3.16 SKIN DNA TEST
7.4 STD TEST
7.4.1 HIV TEST
7.4.2 GONORRHEA TEST
7.4.3 SYPHILIS TEST
7.4.4 HERPES TEST
7.4.5 TRICHOMONIASIS
7.4.6 HEPATITIS B
7.4.7 HEPATITIS C
7.4.8 MEASLES
7.4.9 RUBELLA
7.4.10 VARICELLA
7.4.11 CHLAMYDIA TEST
7.4.12 OTHERS
7.5 NUTRITION
7.5.1 VITAMINS
7.5.1.1 D3
7.5.1.2 B12
7.5.1.3 ACTIVE B12
7.5.2 VITALITY
7.5.2.1 HEALTH MARKERS
7.5.2.2 IRON STATUS
7.5.2.3 MINERALS
7.5.3 OMEGA 3 TEST
7.5.4 IODINE DEFICIENCY TEST
7.5.5 ZINC TEST
7.5.6 SELENIUM TEST
7.5.7 MAGNESIUM BLOOD TEST
7.5.8 FERRITIN TEST
7.5.9 AMINO ACID TEST
7.6 PREGNANCY TEST
7.6.1 STRIP TESTS
7.6.2 MIDSTREAM TEST
7.6.3 CASSETTE TEST
7.6.4 DIGITAL TEST
7.6.5 HCG URINE TEST
7.6.6 HCG BLOOD TEST
7.6.7 LH URINE TEST
7.6.8 FSH URINE TEST
7.7 DRUG ABUSE TEST KITS
7.7.1 MARUUANA KITS
7.7.2 OPIATES KITS
7.7.3 ALCOHOL KITS
7.7.4 OTHERS
7.8 OVULATION PREDICTOR TEST KIT
7.9 OTHERS TEST TYPES
7.9.1 MALE INFERTILITY TEST TYPE
7.9.2 URINARY TRACT INFECTIONS TEST
7.9.3 MENOPAUSE TEST KITS
7.9.4 FECAL OCCULT BLOOD TEST
7.9.5 OTHERS
8 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE
8.1 OVERVIEW
8.2 STRIP
8.2.1 RETAIL PHARMACIES
8.2.2 ONLINE PHARMACIES
8.2.3 DRUG STORE
8.2.4 SUPERMARKET/HYPERMARKET
8.2.5 CASSETTES
8.2.6 RETAIL PHARMACIES
8.2.7 ONLINE PHARMACIES
8.2.8 DRUG STORE
8.2.9 SUPERMARKET/HYPERMARKET
8.2.10 MIDSTREAM
8.2.11 RETAIL PHARMACIES
8.2.12 ONLINE PHARMACIES
8.2.13 DRUG STORE
8.2.14 SUPERMARKET/HYPERMARKET
8.2.15 DIP CARD
8.2.16 RETAIL PHARMACIES
8.2.17 ONLINE PHARMACIES
8.2.18 DRUG STORE
8.2.19 SUPERMARKET/HYPERMARKET
8.2.20 TEST PANEL
8.2.21 RETAIL PHARMACIES
8.2.22 ONLINE PHARMACIES
8.2.23 DRUG STORE
8.2.24 SUPERMARKET/HYPERMARKET
8.3 OTHERS
9 GERMANY AT-HOME TESTING KITS MARKET, BY AGE
9.1 OVERVIEW
9.2 ADULT
9.3 GERIATRIC
9.4 PEDIATRIC
10 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE
10.1 OVERVIEW
10.2 DISPOSABLE
10.3 REUSABLE
11 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE
11.1 OVERVIEW
11.2 BLOOD
11.3 SALIVA
11.4 URINE
11.5 OTHER SAMPLE TYPES
12 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME
12.1 OVERVIEW
12.2 MIDDLE INCOME
12.3 LOW INCOME
12.4 HIGH INCOME
13 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 RETAIL PHARMACIES
13.3 ONLINE PHARMACIES
13.4 DRUG STORE
13.5 SUPERMARKET/HYPERMARKET
14 GERMANY AT-HOME TESTING KITS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUS ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 F. HOFFMANN- LA ROCHE LTD
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 SIEMENS HEALTHCARE GMBH
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 QUIDEL CORPORATION.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 CARDINAL HEALTH.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 ASCENSIA DIABETES CARE HOLDINGS AG.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 B. BRAUN SE MELSUNGEN AG
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BIOLYTICAL LABORATORIES INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BTNX INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CARE DIAGNOSTICA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 DEXCOM, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 DRÄGERWERK AG & CO. KGAA
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 JOHNSON & JOHNSON SERVICES, INC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 KIWENO GMBH
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 MP BIOMEDICALS.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENTS
16.16 NOVA BIOMEDICAL
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 PIRAMAL ENTERPRISES LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENTS
16.18 PRIMA LAB SA
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 SELFDIAGNOSTICS OU
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 SA SCIENTIFIC LTD.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 PRICES OF PRODUCTS OFFERED BY SOME OF THE COMPANIES:
TABLE 2 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 3 GERMANY HEALTH IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 4 GERMANY BEAUTY AND WELLNESS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 GERMANY SEX HORMONE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 6 GERMANY INTOLERANCE TESTING IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 7 GERMANY STD TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 8 GERMANY NUTRITION IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 9 GERMANY VITAMINS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 10 GERMANY VITALITY IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 11 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY PRODUCT, 2021-2030 (USD MILLION), 2021-2030 (USD MILLION)
TABLE 12 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 13 GERMANY DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 14 GERMANY OTHER TEST TYPE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 15 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 GERMANY STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)
TABLE 17 GERMANY CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)
TABLE 18 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)
TABLE 19 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)
TABLE 20 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)
TABLE 21 GERMANY AT-HOME TESTING KITS MARKET, BY AGE, 2021-2030 (USD MILLION)
TABLE 22 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE, 2021-2030 (USD MILLION)
TABLE 23 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 24 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME, 2021-2030 (USD MILLION)
TABLE 25 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 2 GERMANY AT-HOME TESTING KITS MARKET: DATA TRIANGULATION
FIGURE 3 GERMANY AT-HOME TESTING KITS MARKET: DROC ANALYSIS
FIGURE 4 GERMANY AT-HOME TESTING KITS MARKET: GERMANY VS REGIONAL MARKET ANALYSIS
FIGURE 5 GERMANY AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GERMANY AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID
FIGURE 7 GERMANY AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GERMANY AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 10 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES IS EXPECTED TO DRIVE GERMANY AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 11 HEALTH SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GERMANY AT HOME TESTING KITS MARKET
FIGURE 13 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022
FIGURE 14 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 15 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 16 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 17 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2022
FIGURE 18 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2021-2030 (USD MILLION)
FIGURE 19 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 20 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2022
FIGURE 22 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2023-2030 (USD MILLION)
FIGURE 23 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2023-2030)
FIGURE 24 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE
FIGURE 25 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2022
FIGURE 26 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2023-2030 (USD MILLION)
FIGURE 27 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2023-2030)
FIGURE 28 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE
FIGURE 29 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022
FIGURE 30 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021-2030 (USD MILLION)
FIGURE 31 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2023-2030)
FIGURE 32 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 33 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2022
FIGURE 34 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2021-2030 (USD MILLION)
FIGURE 35 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, CAGR (2023-2030)
FIGURE 36 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, LIFELINE CURVE
FIGURE 37 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 38 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 39 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 40 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 GERMANY AT-HOME TESTING KITS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。